NDC 0169-4303 – Rybelsus
Semaglutide 3 mg/1 · Tablet · Oral
Product NDC0169-4303
Product details
- Brand name
- Rybelsus
- Generic name
- Oral semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA213051
- Marketed since
- September 20, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist
Active ingredients
- Semaglutide 3 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0169-4303-30 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-4303-30) | Oct 4, 2021 |
| 0169-4303-99 sample | 30 TABLET in 1 BOTTLE, PLASTIC (0169-4303-99) | Oct 4, 2021 |
Recalls mentioning this NDC
- D-0536-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.